Overview
Chikako Ohwada practices in Narita, Japan. Ohwada is rated as an Experienced expert by MediFind in the treatment of Pure Red Cell Aplasia. Their top areas of expertise are POEMS Syndrome, Graft Versus Host Disease (GvHD), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Tissue Biopsy.
Their clinical research consists of co-authoring 82 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pure Red Cell Aplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- POEMS SyndromeOhwada isDistinguished. Learn about POEMS Syndrome.
- Advanced
- Bone Marrow TransplantOhwada isAdvanced. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Ohwada isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaOhwada isExperienced. Learn about Anemia.
- B-Cell LymphomaOhwada isExperienced. Learn about B-Cell Lymphoma.
- Bronchiolitis ObliteransOhwada isExperienced. Learn about Bronchiolitis Obliterans.
- Chronic Graft Versus Host Disease (cGvHD)